Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.72 |
| ▸ | NPC1 | O15118 | 1/20 | 0.66 |
| ▸ | RAB9A | P51151 | 1/20 | 0.66 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.61 |
| ▸ | RAD52 | P43351 | 1/20 | 0.60 |
| ▸ | UBE2N | P61088 | 1/20 | 0.60 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.60 |
| ▸ | IDO1 | P14902 | 1/20 | 0.60 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL524002 | 1.00 | POLB (0.72) | POLBNPC1RAB9ADDAH1RAD52 | |
| Hydrochloric Acid SCHEMBL2454024 | 0.98 | POLB (0.70) | POLBNPC1RAB9ADDAH1RAD52 | |
| Hydrochloric Acid SCHEMBL28373229 | 0.98 | POLB (0.70) | POLBNPC1RAB9ADDAH1RAD52 | |
| Hydrochloric Acid SCHEMBL7413158 | 0.96 | POLB (0.68) | POLBNPC1RAB9ADDAH1RAD52 | |
| SCHEMBL29505763 | 0.89 | POLB (0.79) | POLBNPC1RAB9ADDAH1CHRM1 | |
| SCHEMBL856769 | 0.89 | POLB (0.79) | POLBNPC1RAB9ADDAH1CHRM1 | |
| SCHEMBL230157 | 0.88 | POLB (0.84) | POLBNPC1RAB9ADDAH1CHRM1 | |
| Hydrochloric Acid SCHEMBL8327038 | 0.87 | POLB (0.77) | POLBNPC1RAB9ADDAH1CHRM1 | |
| SCHEMBL1884524 | 0.87 | POLB (0.83) | POLBNPC1RAB9ADDAH1CHRM1 | |
| SCHEMBL4704495 | 0.86 | POLB (0.80) | POLBNPC1RAB9ADDAH1CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026101698-A1 | HEPCIDIN MIMETIC COMPOUNDS AND USES THEREOF | PROTAGONIST THERAPEUTICS, INC. (US) | 2026-05-15 | — | — | WO | disclosed |
| EP-4681712-A2 | PROCESS FOR THE PRODUCTION OF FERROPORTIN INHIBITORS | VIFOR (INTERNATIONAL) AG (CH) | 2026-01-21 | — | — | EP | disclosed |
| EP-4126854-B1 | PROCESS FOR THE PRODUCTION OF FERROPORTIN INHIBITORS | VIFOR INT AG (CH) | 2025-12-03 | — | — | EP | disclosed |
| US-20250129021-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | Interdict Bio, Inc. (US) | 2025-04-24 | — | — | US | disclosed |
| CN-119528886-B | Shearing inhibitor for pre-miR-21 post-transcriptional processing and preparation method and application thereof | 广东工业大学 | 2025-04-18 | — | — | CN | disclosed |
| WO-2025064718-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | Interdict Bio, Inc. (US) | 2025-03-27 | — | — | WO | disclosed |
| CN-119528886-A | Shearing inhibitor for pre-miR-21 post-transcriptional processing and preparation method and application thereof | 广东工业大学 | 2025-02-28 | — | — | CN | disclosed |
| CN-119384474-A | Liquid composition and optical film | 日本瑞翁株式会社 | 2025-01-28 | — | — | CN | disclosed |
| CN-119053889-A | Multilayer film, method for producing same, polarizing plate, and organic electroluminescent image display device | 日本瑞翁株式会社 | 2024-11-29 | — | — | CN | disclosed |
| CN-117957114-A | Multilayer film, optical multilayer film, and method for producing same | 日本瑞翁株式会社 | 2024-04-30 | — | — | CN | disclosed |
| US-20240124404-A1 | COMPOSITION FOR TREATING DISEASES RELATED TO ADVANCED GLYCATION END PRODUCTS COMPRISING INDOLE DERIVATIVE | METACEN THERAPEUTICS (KR) | 2024-04-18 | — | — | US | disclosed |
| US-20240124305-A1 | PROCESS FOR SIMULTANEOUS REMOVAL OF HYDROGEN SULFIDE AND HEAVY METALS | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-04-18 | — | — | US | disclosed |
| EP-4326717-A1 | MODIFIED FERROPORTIN INHIBITORS | VIFOR (INTERNATIONAL) AG (CH) | 2024-02-28 | — | — | EP | disclosed |
| CN-116829532-A | Substituted cyclohexane carboxamides, their preparation and their therapeutic use | 赛诺菲 | 2023-09-29 | — | — | CN | disclosed |
| CN-116810216-A | Water-soluble pre-flux and surface treatment method | 株式会社田村制作所 | 2023-09-29 | — | — | CN | disclosed |
| CN-111443415-B | Polarizing plate | 住友化学株式会社 | 2023-08-01 | — | — | CN | disclosed |
| CN-111781342-B | Sensitization type SPR immunosensor constructed by gold-magnetic composite nano-meter detects carbendazim | 中国医学科学院药用植物研究所 | 2023-07-07 | — | — | CN | disclosed |
| WO-2022223689-A1 | MODIFIED FERROPORTIN INHIBITORS | VIFOR (INTERNATIONAL) AG (CH) | 2022-10-27 | — | — | WO | disclosed |
| EP-3841102-B1 | TETRAHYDROPYRIDOPYRIMIDINE DERIVATIVES AS AHR MODULATORS | JAGUAHR THERAPEUTICS PTE LTD (SG) | 2022-09-14 | — | — | EP | disclosed |
| CN-110229366-B | Multilayer film and method for producing same | 日本瑞翁株式会社 | 2022-05-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240124404-A1 | COMPOSITION FOR TREATING DISEASES RELATED TO ADVANCED GLYCATION END PRODUCTS COMPRISING INDOLE DERIVATIVE | AGER, IDO1, IAPP | POLB 3978/4885NPC1 3274/4885RAB9A 3408/4885 |
| US-20250129021-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | MYC, KRAS, NRAS | POLB 1532/4885NPC1 2316/4885RAB9A 583/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.